Clik here to view.
AVEO and CANbridge Life Sciences Announce Exclusive Licensing Agreement for...
CAMBRIDGE, Mass. & BEIJING AVEO Oncology (NASDAQ:AVEO) and CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, today...
View ArticleClik here to view.
Chi-Med Initiates Sulfatinib Phase III Registration Study in Pancreatic...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that Hutchison MediPharma Limited (“HMP”), its drug R&D subsidiary, has initiated SANET-p, a Phase III...
View ArticleClik here to view.
EOS imaging Receives China Food and Drug Administration (CFDA) Approval for...
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced today that the Company has received approval from the China Food and Drug...
View ArticleClik here to view.
がん治療法は自分で選べる時代がん免疫細胞療法セミナー、福岡市で開催、参加者を募集：リンパ球バンク株式会社
東京 （ビジネスワイヤ） — がん免疫治療で先進的な取り組みをしている京都大学発のベンチャー企業、リンパ球バンク株式会社（本社：東京都千代田区、代表取締役：藤井真則）は、今、注目を集めているがん免疫治療について広く知っていただくため、読売新聞西部本社後援・市民公開講座「がん免疫細胞療法セミナー」を4月6日（水）福岡市中央区の読売新聞西部本社にて開催します。先着80名様で参加希望者を募集中です。...
View ArticleClik here to view.
Agilis Biotherapeutics and T-TOP Clinical Research Enter into an Agreement...
CAMBRIDGE, Mass. Agilis Biotherapeutics, LLC (Agilis), a biotechnology company advancing innovative gene therapies for rare genetic diseases that affect the central nervous system (CNS), and T-TOP...
View ArticleClik here to view.
Enhance Your Expertise in Forensic DNA at the 2016 International Symposium on...
MADISON, Wis. Forensic professionals interested in learning about the latest developments in forensic DNA tools, techniques and processes are invited to join scientists, law enforcement...
View ArticleClik here to view.
Solasia Initiates Phase 2 Study of Darinaparsin (SP-02) for Peripheral T-Cell...
TOKYO Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President: Yoshihiro Arai, hereinafter “Solasia”) announced today that an Asian Multinational Phase II study of SP-02 (darinaparsin) for...
View ArticleClik here to view.
Glaukos iStent® Trabecular Micro-Bypass Stent Approved in Japan
LAGUNA HILLS, Calif. Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to...
View ArticleClik here to view.
Announcement on Proposed Conversion of Japanese Subsidiary into the Holding...
SEATTLE Acucela Inc. (located in Seattle, Washington, U.S.A.; the “Company”) (TOKYO:4589), a clinical stage ophthalmology company that specializes in identifying and developing novel therapeutics to...
View ArticleClik here to view.
Quantel Medical Awarded Tender for Ophthalmic Laser Equipment from India...
CLERMONT-FERRAND, France Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases,...
View ArticleClik here to view.
クァンテル・メディカルがインド国防省から眼科レーザー装置の納入契約を落札
仏クレルモンフェラン （ビジネスワイヤ） — 眼科医療機器の世界的企業として眼疾患の診断・治療を改善する有力技術の開発に専心しているクァンテル・メディカル（クァンテル）は、眼科レーザー装置の競争入札で300万ユーロの契約を落札したと発表しました。...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer...
HYDERABAD, India Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy’s will...
View ArticleClik here to view.
Gore上市用于复杂型腹部疝修复的独特生物材料
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天在第17届疝修复年会上宣布上市用于疝修复的独特复合器械GORE®...
View ArticleClik here to view.
Quantel Medical中标印度国防部眼科激光设备
法国克莱蒙费朗 (美国商业资讯) — Quantel Medical (Quantel) 是一家全球性眼科医疗器械公司，致力于开发各类领先技术，以改善眼科疾病的诊疗，该公司宣布已成功中标一批价值300万欧元眼科激光设备。 根据印度国防部武装力量医疗服务总局签署的供货协议条款，Quantel Medical将提供61台光凝固激光仪，供印度53家部队医院使用。配置Suprascan的532nm...
View ArticleClik here to view.
New Clinical Study Reports Relationship Between Masimo’s Oxygen Reserve Index...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today that a new retrospective study reports the relationship between Masimo’s Oxygen Reserve Index (ORI™) and arterial partial pressure of...
View ArticleClik here to view.
Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan
JERUSALEM & OSAKA, Japan Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited (TSE:4502) announce the establishment of Teva Takeda Yakuhin Ltd....
View ArticleClik here to view.
ゴアが複雑な腹壁ヘルニア修復のための独自の生体材料を発表
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® SYNECOR Biomaterialを2016年3月30日～4月2日にワシントンD.C.で開催される第17回年次ヘルニア修復術カンファレンスで披露すると発表しました。GORE® SYNECOR...
View ArticleClik here to view.
マシモの予備酸素摂量（ORI™）と術中動脈血酸素分圧との関係を新しい臨床研究が報告
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、新しい後ろ向き研究でマシモの予備酸素摂量指数（ORI™）と術中の動脈血酸素分圧（PaO2）との関係が報告されたと発表しました。研究はORIとPaO2との関係の傾向に基づき、手術を受けている成人患者における切迫した酸素飽和度低下の先行指標をORIが提供できる可能性を示しています1。 このSmart News...
View ArticleClik here to view.
The Most Natural Breast Enlargement in the World: Right Here in Korea
SEOUL, South Korea Perfect body shape has become a more important factor in determining beauty along with beauty. Increasing number of women are getting breast surgery to create a more feminine body...
View ArticleClik here to view.
Sagging-Free & Sleek: TL Tightening 3D Zygoma Reduction
SEOUL, South Korea Small and slim so called “dolly” face shape is considered as the most attractive facial feature in this era. Tightening 3D Zygoma Reduction is the perfect option for those who...
View Article